Source: Annual Congress 2007 - Therapy of thoracic malignancies
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
K. Lilley, D. Saralaya, D. Newton, A. Dwarakanath, R. Mustafa, B. Jacob (Bradford, United Kingdom). Pathway of lung cancer presentation – does it affect management?. Eur Respir J 2007; 30: Suppl. 51, 2554

Member's Comments

No comment yet.

Related content which might interest you: Delay in the management of lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 322s Year: 2005 How should PET influence the management of lung cancer? Source: Annual Congress 2013 –ME11 How should PET influence the management of lung cancer? Year: 2013 Complexity of diagnostics of complicated lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 39s Year: 2004 Missed lung cancer on chest radiography – does it affect the outcome? Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques Year: 2007 Delays in lung cancer management Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005 Reducing delays in lung cancer diagnostic pathways to improve patient experience Source: International Congress 2016 – Quality management and quality of life in lung cancer Year: 2016 Milestones in the management of lung cancer Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Locally advanced and metastatic lung cancer management delay: Tunisian department experience Source: International Congress 2016 – Quality management and quality of life in lung cancer Year: 2016 Poor performance status patient in advanced lung cancer: to treat or not to treat? Source: Annual Congress 2008 - MP13 - Poor performance status patient in advanced lung cancer: to treat or not to treat? Year: 2008 Nurse led lung cancer diagnostic/supportive follow up clinic;a different approach to optimise lung cancer pathway Source: International Congress 2018 – The many facets of respiratory nursing Year: 2018 Targeted therapies for lung cancer: how did the game begin? Source: Breathe 2016; 12: 177-179 Year: 2016 An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Year: 2006 Impact of COPD on prognosis of lung cancer: the prespective of immunotherapy treatment Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021 Panel discussion: Improving the pathway of lung cancer patients, can we do it better? Source: ERS webinar 2021: Panel discussion on improving the pathway of lung cancer patients, can we do it better? Year: 2021 Novel aspects in lung cancer pathology: how does it help for selecting chemotherapy? Source: Annual Congress 2010 - PG4 Core Curriculum Postgraduate Course: Pathology for the clinician Year: 2010 Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019